FRIDAY, March 22, 2024 (HealthDay News) — Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday. The move comes after the U.S. Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label earlierContinue Reading

WEDNESDAY, March 13, 2024 (HealthDay News) — Following a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day. That estimate was generatedContinue Reading

WEDNESDAY, Dec. 13, 2023 (HealthDay News) — An overwhelming majority of older Americans think health insurers and Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy or Zepbound, a new survey has found. More than four out of five older adults (83%) think insurance companies should pay forContinue Reading

THURSDAY, Nov. 16, 2023 (HealthDay News) — If you need medical care, you’re more likely to skip it due to cost issues if you’re American than if you’re Australian, Canadian, British or French, a new report finds. Rising costs aren’t just causing poorer Americans to forgo needed care: The CommonwealthContinue Reading

THURSDAY, Oct. 19, 2023 (HealthDay News) — Americans with Down syndrome have a critical lifeline in Medicaid insurance, new research confirms. But the publicly funded insurance program will have to respond to rising numbers of older adults with Down syndrome, researchers say. “As more people with Down syndrome survive toContinue Reading

FRIDAY, Sept. 29, 2023 (HealthDay News) – Despite reports of trouble last week where some people may have been denied insurance coverage while seeking COVID shots at pharmacies, the Biden administration said Thursday those issues have been ironed out. That issue is “largely, if not completely,” resolved after U.S. HealthContinue Reading

FRIDAY, Sept. 22, 2023 (HealthDay News) — Americans seeking out the new COVID boosters are finding themselves held back by insurance entanglements and supply delays. Some insurers have balked at covering the vaccines, with people arriving at shot appointments only to be told that they’ll have to pay $100 orContinue Reading